What's Going On with Tranq?
Briefly

Xylazine, labeled as 'tranq,' is detected in black-market fentanyl across multiple U.S. states, contributing to overdose deaths and alarming health authorities.
Xylazine's use, approved for animal sedation by the FDA, when mixed with fentanyl by drug dealers, causes dangerous effects like sedation and severe wounds.
Xylazine's inclusion in opioids began in the early 2010s, unnoticed due to low concentrations, becoming a significant concern due to higher prevalence now.
Adding xylazine to fentanyl aids in administration due to fentanyl's tiny dosage, making it visible and usable, as explained by medical toxicologist Lewis Nelson.
Read at Slate Magazine
[
]
[
|
]